Insider · CIK 0001827584

Neervannan Seshadri

Reports to the SEC for 1 company · IRVINE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001827584

Forms 4 and 5

Insider transactions

43 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-04	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−4,564 sh	$85.00	−$388K	78,532
2026-03-20	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−2,989 sh	$66.75	−$200K	82,791
2026-03-19	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−4,589 sh	$67.00	−$307K	85,780
2026-03-18	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−3,610 sh	$68.71	−$248K	90,369
2026-03-17	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−3,125 sh	$69.42	−$217K	93,979
2026-03-15	TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+26.3K sh	—	—	97,104
2026-03-15	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−5,097 sh	—	—	0
2026-03-15	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−8,148 sh	—	—	8,148
2026-03-15	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−8,020 sh	—	—	16,040
2026-03-15	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−5,022 sh	—	—	15,067
2026-03-05	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+27.3K sh	—	—	27,310
2026-03-05	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Operating Officer	AAward	+17.2K sh	—	—	17,161
2026-03-04	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−8,366 sh	$76.67	−$641K	70,817
2025-12-16	TARSTarsus Pharmaceuticals, Inc.G Gift	Chief Operating Officer	GGift	−950 sh	—	—	79,183
2025-12-16	TARSTarsus Pharmaceuticals, Inc.G Gift	Chief Operating Officer	GGift	+475 sh	—	—	475
2025-03-20	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−2,435 sh	$50.11	−$122K	79,682
2025-03-19	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−2,543 sh	$47.40	−$121K	82,117
2025-03-18	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−2,605 sh	$46.29	−$121K	84,660
2025-03-15	TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+21.3K sh	—	—	87,265
2025-03-15	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−5,097 sh	—	—	5,097
2025-03-15	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−8,148 sh	—	—	16,296
2025-03-15	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−8,019 sh	—	—	24,060
2025-03-05	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+30.6K sh	—	—	30,628
2025-03-05	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Operating Officer	AAward	+20.1K sh	—	—	20,089
2024-03-18	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−4,879 sh	$30.60	−$149K	64,767
2024-03-15	TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+13.2K sh	—	—	69,646
2024-03-15	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−5,097 sh	—	—	10,194
2024-03-15	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−8,148 sh	—	—	24,444
2024-03-07	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+47.5K sh	—	—	47,500
2024-03-07	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Operating Officer	AAward	+32.1K sh	—	—	32,079
2023-03-23	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−390 sh	$12.15	−$4,738.5	54,696
2023-03-22	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−379 sh	$12.64	−$4,790.56	55,086
2023-03-21	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−372 sh	$12.89	−$4,795.08	55,465
2023-03-20	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−380 sh	$12.61	−$4,791.8	55,837
2023-03-17	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−360 sh	$13.28	−$4,780.8	56,217
2023-03-16	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−357 sh	$13.43	−$4,794.51	56,577
2023-03-15	TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+5,097 sh	—	—	56,934
2023-03-15	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−5,097 sh	—	—	15,291
2023-03-08	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+48.1K sh	—	—	48,116
2023-03-08	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Operating Officer	AAward	+32.6K sh	—	—	32,592
2022-03-09	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+69.5K sh	—	—	69,498
2022-03-09	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Operating Officer	AAward	+20.4K sh	—	—	20,388
2021-01-07	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+61.5K sh	—	—	61,499

Recent filings

Accepted (ET)
Sep 94
Neervannan Seshadri0001827584-26-000013
SEC(opens sec.gov)
Mar 244
Neervannan Seshadri0001827584-26-000011
SEC(opens sec.gov)
Mar 194
Neervannan Seshadri0001827584-26-000009
SEC(opens sec.gov)
Mar 174
Neervannan Seshadri0001827584-26-000007
SEC(opens sec.gov)
Mar 94
Neervannan Seshadri0001827584-26-000005
SEC(opens sec.gov)
Mar 54
Neervannan Seshadri0001827584-26-000002
SEC(opens sec.gov)
Dec 184
Neervannan Seshadri0001827584-25-000003
SEC(opens sec.gov)
Mar 204
Neervannan Seshadri0001819790-25-000058
SEC(opens sec.gov)
Mar 184
Neervannan Seshadri0001819790-25-000043
SEC(opens sec.gov)

Companies

Tarsus Pharmaceuticals, Inc.Chief Operating OfficerTARS

Address

C/O TARSUS PHARMACEUTICALS, INC. 17700 LAGUNA CANYON ROAD, FLOOR 4

IRVINE, CA, 92618